Market Research Logo

Global Anemia Therapeutics Market 2017-2021

Global Anemia Therapeutics Market 2017-2021

About Anemia Therapeutics

It is a medical condition that is characterized by the decrease in RBC count. RBCs make up the blood, and its main function is to deliver oxygen from lungs to other tissues and carbon dioxide from other tissues back to the lungs. This function is accomplished by hemoglobin, an iron-containing biomolecule present at the cytoplasm of an RBC and can efficiently bind to oxygen. In anemia, the decreased RBC count results in the impairment of the body's ability for gas exchange (oxygen and carbon dioxide). This decrease may result from hemolysis (destruction of RBC), hemorrhage (blood loss), or decreased production of RBCs.

Technavio’s analysts forecast the global anemia therapeutics market to grow at a CAGR of 8.55% during the period 2017-2021 .

Covered in this report

The report covers the present scenario and the growth prospects of the global anemia therapeutics market for 2017-2021 . To calculate the market size, the report considers the sales of branded, generic, and off-label drugs used for the treatment of anemia.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Anemia Therapeutics Market 2017-2021 , has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AMAG Pharmaceuticals
  • Daiichi Sankyo
  • Galenica
  • Pharmacosmos
Other prominent vendors
  • Acceleron Pharma
  • Bayer
  • GlycoMimetics
  • GlaxoSmithKline
  • Novartis
  • Pieris Pharmaceuticals
  • Sanofi
Market driver
  • Presence of large patient pool with various disorders
  • For a full, detailed list, view our report
Market challenge
  • High cost of drugs
  • For a full, detailed list, view our report
Market trend
  • Growing focus on emerging economies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Anemia Therapeutics Market 2017-2021

Technavio recognizes the following companies as the key players in the global anemia therapeutics market: AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, and Pharmacosmos

Other Prominent Vendors in the market are: Acceleron Pharma, Bayer, GlycoMimetics, GlaxoSmithKline, Novartis, Pieris Pharmaceuticals, and Sanofi.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Growing focus on emerging economies. The growing focus of vendors on emerging economies will create growth opportunities. The emerging countries such as China, India, and Brazil are witnessing an increased prevalence of CKD and other diseases such as congestive heart failure. This has driven vendors to focus on emerging economies, which will enable them to expand their sources of revenue.”

According to the report, one of the major drivers for this market is Presence of large patient pool with various disorders. Intravenous anemia therapeutics have increased in demand owing to the presence of large patient pools globally. Some of the risk factors that lead to anemia include CKD, non-dialysis CKD, congestive heart failure, chemotherapy-induced anemia, inflammatory bowel syndrome, surgeries, heavy uterine bleeding, and postpartum depression. As per the NIH, an estimated 200 million globally, were suffering from CKD in 2014, with low to middle income countries leading the chart. Most of the deaths related to the kidney occur in developing countries largely due to expensive treatment and inappropriate healthcare infrastructure.

Further, the report states that one of the major factors hindering the growth of this market is High cost of drugs. The high cost of drugs associated with the use of anemia therapeutics, particularly the intravenous iron drugs used for the treatment of iron deficiency anemia, may pose a challenge to the market. There are many benefits of intravenous iron drugs over oral iron drugs. However, intravenous iron drugs are costlier than oral iron drugs. This may hinder the adoption rates of intravenous iron drugs and may drive end-users to choose low-cost alternatives.

Companies Mentioned

AMAG Pharmaceuticals, Daiichi Sankyo, Galenica, Pharmacosmos, Acceleron Pharma, Bayer, GlycoMimetics, GlaxoSmithKline, Novartis, Pieris Pharmaceuticals, and Sanofi.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
  • Anemia: A brief overview
    • Anemia
      • Table Complications arising due to anemia
    • Symptoms
      • Table Symptoms of anemia
    • Classification of anemia
      • Table Classification of anemia
    • Causes of anemia
      • Table Causes of anemia
    • Treatment
      • Table Treatment approaches for anemia
  • Market landscape
    • Market overview
      • Table Global anemia therapeutics market
      • Table Global anemia therapeutics market, 2016-2021 ($ billions)
      • Table Use of anemia therapeutics
      • Table Opportunity analysis of global anemia therapeutics market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline Landscape
    • Table Pipeline landscape by number of molecules
    • Table Key clinical trials
  • Market segmentation by disease type
    • Table Global anemia therapeutics market segmentation by disease type
    • Table Global anemia therapeutics market share by disease type, 2016
    • Iron deficiency anemia
      • Table Global iron deficiency anemia therapeutics market, 2016-2021 ($ billions)
    • Sickle cell anemia
      • Table Global sickle cell anemia therapeutics market, 2016-2021 ($ billions)
    • Pernicious anemia
      • Table Global pernicious anemia therapeutics market, 2016-2021 ($ billions)
    • Hemolytic anemia
      • Table Types of hemolytic anemia
      • Table Global hemolytic anemia therapeutics market, 2016-2021 ($ billions)
    • Others
      • Table Global anemia therapeutics market by others, 2016-2021 ($ billions)
  • Geographical segmentation
    • Table Global anemia therapeutics market share by geography, 2016 and 2021
    • Table Global anemia therapeutics market by geography, 2016-2021 ($ billions)
    • Anemia therapeutics market in Americas
      • Table Market scenario in Americas
      • Table Anemia therapeutics market in Americas ($ billions)
    • Anemia therapeutics market in EMEA
      • Table Market scenario in EMEA
      • Table Anemia therapeutics market in EMEA ($ billions)
    • Anemia therapeutics market in APAC
      • Table Market scenario in APAC
      • Table Anemia therapeutics market in APAC ($ billions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Growing focus on HIF stabilizers
    • Growing focus on emerging economies
    • Increasing strategies of vendors to expand reach of anemia therapeutics
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global anemia therapeutics market 2016
  • Key vendor analysis
    • AMAG Pharmaceuticals
      • Table AMAG Pharmaceuticals: Key highlights
      • Table AMAG Pharmaceuticals: Strength assessment
      • Table AMAG Pharmaceuticals: Strategy assessment
      • Table AMAG Pharmaceuticals: Opportunity assessment
    • Daiichi Sankyo
      • Table Daiichi Sankyo: Key highlights
      • Table Daiichi Sankyo: Strength assessment
      • Table Daiichi Sankyo: Strategy assessment
      • Table Daiichi Sankyo: Opportunity assessment
    • Galenica
      • Table Galenica: Key highlights
      • Table Galenica: Strength assessment
      • Table Galenica: Strategy assessment
      • Table Galenica: Opportunity assessment
    • Pharmacosmos
      • Table Pharmacosmos: Key highlights
      • Table Pharmacosmos: Strength assessment
      • Table Pharmacosmos: Strategy assessment
      • Table Pharmacosmos: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report